Friday 27 December 2019

Stem cell therapy Market to Witness a Healthy CAGR Growth of 10.3% by 2023

Market overview
The worldwide stem cell therapy market is expected to attain an estimated CAGR of 10.3% over the forecast period. The application of stem cell for curing medical conditions is known as stem cell therapy.
The global stem cell therapy market is anticipated to rise due to the growing awareness for therapeutic application of stem cells in increasing research for stem cell therapy applications, disease management, advancement of genetic analysis techniques, boosting studies in identification of new stem cell lines, developments in stem cell banking infrastructure and increasing public-private fundings for stem cell research are factors influencing the global stem cell therapy market. Stem cell finds its applications in the cure of Alzheimer’s where affected cells are replaced by stem cells. The approach has huge potential in halting or preventing different neurodegenerative ailments like Alzheimer’s.  A study by Alzheimer's Association in 2018, states that 5.7 million Americans got affected by the Alzheimer’s disease. 
Market Analysis
Stem-cell therapy simply put is the utilization of stem cells for preventing or treating a condition or disease. For over 55 years, stem cells have been used for treating serious diseases including cancer, dementia, type 1 diabetes, arthritis, stroke, heart disease, Alzheimer’s disease, amyotrophic lateral sclerosis, Parkinson’s disease, spinal cord injuries, burns and osteoarthritis. The stem cells are generally undifferentiated cells which are differentiated into the specialized cell types. There are a couple of key factors that is responsible for the massive growth of the global stem cell therapy market. These include new developments in the banking infrastructure of stem cells, increasing research in new stem cell line identification, rising public-private investment in stem cell research, development of latest genetic analysis techniques, increasing research for application of stem cell therapy and the increasing awareness for stem cells therapeutic application in disease management.
Stem cells are used for treating Alzheimer’s disease by using stem cells in place of the diseased cells. This method has an excellent potential to halt or prevent different forms of neurodegenerative diseases. More than 5.7 million Americans were diagnosed with Alzheimer’s disease as reported by the Alzheimer’s Association in 2018. It is the increasing government funding and rising number of neurological diseases that has boost up the stem cell therapy market. But there are some factors however that may restrict the growth of the market during the forecast period. These include regulatory complications, lack of skilled labor exclusive procedures, cross contaminations and difficulty of collection as well as storage techniques of the somatic stem cells. The global stem cell therapy market is likely to touch at 10.3% CAGR during the forecast period.
Market Segmentation
In MFRF’s report, the global stem cell therapy market is segmented on the basis of type, therapeutic application, cell source and end-user.
On the basis of type, it is segmented into autologous and allogeneic. The latter had the largest market share in 2016 for a couple of reasons such as growing commercialization of allogeneic products, its higher therapeutic applications and rising clinical trials associated to this therapy.
On the basis of therapeutic application, it is segmented into diabetes, immunodeficiency, cancer, metabolic disorders, hematopoietic disorders, treatment of eyes, wound healing, neurodegenerative disorders, bone regeneration, cardiovascular disease and medicine.
On the basis of cell source, it is segmented into iPSCs, cord/embryo blood-derived, neural, bone marrow and adipose tissue.
On the basis of end-user, the stem cell therapy market is segmented into stem cell banks, contract research organizations, research institutes, hospitals and biotechnology companies.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , ,

You Will Never Thought That Knowing Autism Disorder And Treatment Market Could Be So Beneficial!

Worldwide Autism Disorder and Treatment Market is relied upon to develop at a CAGR of 4.37% during the figure time frame 2017–2023.
Autism Spectrum Disorder (ASD) is a scope of conditions brought about by difficulties with social abilities, discourse and nonverbal correspondence, dreary practices, alongside one of a kind qualities and contrasts. This condition is brought about by various mixes of hereditary and natural impacts. Autism will in general give its most-clear indications somewhere in the range of two and three years old. In different cases, it tends to be analyzed inside year and a half of the kid's introduction to the world.
The worldwide autism disorder and treatment market has been distinguished as one of the quickly developing enterprises, attributable to rising predominance of autism and Pervasive Developmental Disorder (PDD) and rising mindfulness about autism among the patient populace. Autism disorder and treatment is seen as one of the altogether developing markets in the medicinal services segment on account of activities taken by the legislature of different countries and expected endorsements of different off-name treatment treatments by the Food and Drug Association (FDA).
Competitive Analysis:
Some of the major companies in the global autism disorder and treatment market include Pfizer Inc., Allergan, Eli Lilly and Company, Merck & CO Inc., Consern Pharma Private Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Bristol-Myers Squibb and Otsuka Holdings Co., Ltd., Johnson & Johnson Services, Inc., Coronis Partners Ltd., and Curemark LLC.
Segmentation:
The autism disorder and treatment market is segmented on type, treatment type, drug, and region.
By type, it is segmented into pervasive developmental disorder, asperger syndrome, and others.
By treatment type, it is segmented into oxytocin therapy, hyperbaric oxygen therapy, ABA (applied behavioral analysis), chelation therapy, and others. Of these, the ABA is the largest segment, and is expected to expand at a rate of CAGR 4.82% over the forecast period
By drug, it is segmented into anti-convulsant, SSRIs, stimulants, and anti-psychotic. Of these, anti-psychotics are further segmented into Abilify (aripiprazole) and Risperidone. Of these, the anti-psychotic segment accounted for the largest market share in global autism disorder and treatment market and is expected grow with the CAGR of 3.95% for the forecast period.

Trending Reports




About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Tuesday 24 December 2019

Stem Cell Reconstructive Market to Expand at a Robust CAGR of 22.6% Between 2017 and 2023

/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Stem Cell Reconstructive Market.

Stem cell reconstructive is a procedure involving the usages of a patient’s own adipose tissue to increase the fat volume in the area of reconstruction and thus promoting 3Dimentional reconstruction in patients who have undergone a trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or who need the reconstructive surgery as a result of an accident or injury. Stem cell reconstructive surgeries are also used in cosmetic or plastic surgeries.
Over the past few years, increasing reconstructive surgeries led by the increasing number of accidents, limbs amputation and implants are fostering the growth in the stem cell reconstructive market. Besides, the factors such as increasing geriatric populations, rising number of patients suffering from chronic diseases, and continuous development in the technology are escalating the market on the global level.
Acknowledging the kind of growth this market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the booming, global stem cell reconstructive market will register a whopping double digit CAGR of 22.6% during the forecast period 2017-2023.
Growing demand for fat & skin grafting procedures is a key driving force behind the market growth. Moreover, the growing prevalence of obesity is fostering the market growth of stem cell reconstructive, driving the plastic surgery & integumentary system market.

Growing demand for facial aesthetic treatments, technological advancements in the plastic surgery industry, high demand for the plastic surgery & integumentary system application such as facelift procedures is some of the significant factors that are driving the market growth of stem cell reconstructive surgeries. Additionally, the growing prevalence of skin diseases and increased activities in research laboratories, pharmaceutical and dermatology companies are fostering the market growth further.
On the other hand, factors such as high cost of stem cell reconstructive surgeries and stringent regulatory approvals are acting as a headwind obstructing the market growth. Besides, high risks of adverse effects associated with these surgeries can also impede the market growth. Nevertheless, factors such as the increasing need for alternative treatments, government support for the development of new products, and rising healthcare expenditure are expected to support the market growth over the assessment period. 

Stem Cell Reconstructive Market - Segments
MRFR has segmented its analysis into five key dynamics for the convenience of understanding;
By Sources: Allogeneic, Autologous (bone marrow, adipose tissue, and blood.), and Syngeneic among other.
By Cell Types: Embryonic Stem Cell and Adult Stem Cell among others.
By Applications: Cancer, Diabetes, Traumatic Skin Defect, and Severe Burn among others.
By End-Users: Hospital and Research Institutes among others.
By Regions:  Europe, North America, APAC and the Rest-of-the-World (RoW). 

Stem Cell Reconstructive Market - Regional Analysis
Globally North America market dominates the stem cell reconstructive market with the largest share. Factors such as the notable increase in incidences of stem cell reconstructive surgeries and encouraging research and development in healthcare drive the market growth in the region. Additional factors such as the increasing uptake of advanced technologies and high healthcare expenditures are substantiating the market growth.
Owing to the rising demands for stem cell reconstructive procedures, this market is expected to create a larger revenue pocket globally, by 2023. The US among other North American countries, backed by the high expenditure on healthcare coupled with the increasing demand for stem cell reconstructive treatments, accounts for the major contributor to the market growth.
The European accounts for the second largest market for stem cell reconstructive, globally, attributing to the recent advancements in the medical technology and the augmenting these techniques in the region.  Additionally, the presence of a substantial patient population alongside the rising healthcare expenditure facilitates the growth of the regional market. Besides, public & private sectors' support and funding for research & development are expected to fuel the market growth in the region over the review period.
The Asia Pacific region is rapidly emerging as a lucrative market for stem cell reconstructive due to the increasing incidents of these surgeries and the development of related technologies mainly in the countries such as India, China, and Japan. The APAC market backed by the rising demand for these procedures and increasing adoption of the technologies is projected to register a phenomenal CAGR during the forecast period.
Global Stem Cell Reconstructive Market - Competitive Analysis
The fiercely competitive stem cell reconstructive market appears fragmented due to the presence of many well-established as well as small & new entrants. Innovation/ new technology launch remain the popular trends among the key market players. The growth statistics of the market presage the probable heights the market can reach further.


Key Players:
The global stem cell reconstructive market is led by some of the fervent players including Cytori Therapeutics Inc. (U.S), Baxter (US), Eleveflow (France), NuVasive Inc. (US), Mesoblast Ltd. (Australia), Osiris Therapeutics, Inc.  (US), TAKARA BIO INC.(Japan), Micronit Microfluidics (Netherlands), Tigenix (Belgium), Celyad (Belgium), Cynata (Australia), Capricor Therapeutics (Canada), Pfizer Inc. (US), Astellas Pharma US, Inc. (US), StemCells Inc (US), Caladrius (US), and STEMCELL Technologies Inc. (US).

Industry/Innovations/Related News:
October 2, 2018 – A team of doctors at the Wolters Kluwer Health (US) published their study of a new technique of repairing cleft palate in infants that they have developed in The Journal of Craniofacial Surgery. These doctors say that it could be a promising new approach to repair of cleft palate in infants. The technique developed in a study led by Dr. Botero, involves usages of umbilical cord blood stem cells.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Monday 23 December 2019

Regional Analysis 3D Printed Medical Implants Market On projected to grow at a CAGR of 18.1% over the forecast period

Market Highlights
The global 3D printed medical implants market held a market value of USD 1,124.68 million in 2018 and is projected to grow at a CAGR of 18.1% over the forecast period.   
3D printing is a procedure that uses a layer by layer method for the creation of a real or physical object from a digital design. This technology is in its early stage in healthcare applications and holds strong potential for a wide variety of applications in medical implants. Factors such as vast technological advancements in the medical device industry and strategic investments done by leading players are expected to drive the market growth. For instance, EnvisionTEC signed a partnership with Abergower as its global reseller partner to expand Envision’s global footprints in 3D printed medical devices market in November 2017. Moreover, the rising need for medical implantation due to the high prevalence of bone-dental disorders are driving the growth of the global 3D printed medical implants market.
On the other hand, the high cost of implants and stringent government regulations are likely to hamper the growth of the market.

Segmentation
The global 3D printed medical implants market has been segmented into component type, implantation technology, application, and end user.
By implantation technology, the market has been segmented into laser beam melting, electronic beam melting, droplet deposition, and others.
Based on application, the market has been segmented into dental, orthopedic, and cranio-maxillofacial.
The market, by end user, has been segmented into hospitals, medical device companies, research and academic institutes, and others.
Key Players
Some of the prominent players in the global 3D printed medical implants market are Materialise (Belgium), Renishaw plc (UK), 3D Systems, Inc. (US), Stratasys Ltd(Israel), ENVISIONTEC, INC. (US), Arcam AB (Sweden), SLM Solutions (Germany), Oxford Performance Materials (US), Bio3D Technologies (Singapore), Cyfuse Biomedical K.K. (Japan), TRUMPF (Germany), ADEISS (US), OsseoMatrix (US), AnatomikModeling (France), EIT Emerging Implant Technologies (Germany).


About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels: , ,

Sunday 22 December 2019

Healthcare Supply Chain Market is highly promising expected to witness a notable CAGR of 40.2%

Market Scenario:
Healthcare supply chain management involves all activities related to the flow of materials such as planning, execution, control, and monitoring in the healthcare business. The market for global healthcare supply chain management Market is projected to grow at a CAGR of 40.2 % during the review period of 2017 to 2023.

Market Dynamics:
Seismic Shift In The Global Business Environment And Growing Complexity Of Management Are The Prime Determinants Of The Market Growth
Growing complexity of business environment such as increasing competition, high operational expenditure, increasing fragmentation of the healthcare industry, shortening product lifecycles, crumbling of trade barriers, supply risks such as political and regional uncertainty, have created antecedents for the adoption of healthcare supply chain management. The situation is compounded by transformation of the internal business environment such as growing organizational size, outsourcing, multiple vendor management, and others.

Advancements In Analytics, Machine Learning, And Big Data Is A Large Market Opportunity
Business can no longer afford to lose on the crucial parameter of the economics of scale and scope generated by optimizing its resources. The advancements in analytics, machine learning and advent of social media, and Big Data will provide a critical advantage to early adopters owing to better business forecasting.
The rise of e-commerce, development of global supply chains and the advent of social media and connected patient communities is expected to trigger greater frequency and intensity of Bullwhip effect result in stockpiling of products and shorter product lifecycles impacting production, planning, and distribution. The advent of Big Data, machine learning, tracking technology such as radio frequency identity tags (RFID) and analytics and is expected to revolutionize the industry.

Need For Business Reorganization, Lack Of Awareness, And Issues Of Integration May Hamper Market Growth
The need for business reorganization, lack of awareness, issues of integration between organizational units, concerns about data security owing to a higher outflow of information may hamper the market. The high cost of installation and maintenance, are the other constraints on the market.

Segments:
To generate an accurate understanding of the global healthcare supply chain management market, the report is segregated by models, functions, delivery mode, software, technology, end users, and regions.
Based on the models, the market is segmented into make-to-stock model, build-to-order, continuous replenishment model, chain assembly and others.
Based on the functions, the market is segmented into forecasting and planning, inventory management and procurement, internal logistics and operations, warehousing and distribution, reverse and extended logistics and others.
Based on the delivery mode, the market is segmented into on-premise and web-based.
Based on the software, the market is segmented into planning tools and execution tools. The planning tools are further sub-segmented into forecasting and inventory management, supplier and vendor management, production and sales planning, others. The execution tools are further sub-segmented into warehouse management, order processing, and status tracking and others.
Based on the technology, the market is segmented into a barcode, radio frequency identification (RFID), a global positioning system (GPS), internet of things and big data, others.
Based on the end users, the market is segmented into pharmaceutical and biotech companies, logistics companies and distributors, healthcare providers and others.
Based on regions, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa.

Regional analysis:
North America led by the U.S. accounts for the most significant market share owing to the faster adoption of technology, the presence of global players and concerns over the healthcare delivery.
Europe led by Germany, U.K., and France is projected to secure the second largest market owing to the creation of the common economic market resulting in the greater cross-border flow of goods.
However, the Asia Pacific region led by China, Japan, and India is expected to be the fastest growing market. The Middle East and Africa market are anticipated to be driven by the Gulf nations of Saudi Arabia, Qatar, and UAE.
Prominent Vendors:
Some of the leading vendors operating in the market are SAP, McKesson, TECSYS, JDA Software, Healthcare Logistics, GHX, VUEMED, Omnicell, OnProcess Technology, Parts Source, Spend Vu, Sterling Oracle, Vizient, Inc., Manhattan Associates, and others.
Industry News:
December 2017 – CVS to acquire Aetna for a momentous USD 69 billion which is expected to create a global behemoth.
November 2017 – JAGGAER, to acquire BravoSolution making JAGGAER the largest vertically focused spend management solutions company.

Trending Reports 


Posted by at No comments:
Labels: , ,

Friday 20 December 2019

Neurovascular Devices Market Revealing Key Drivers, Growth Trends and Competitive Analysis through 2023

Market Research Future Published a Half-Cooked Research Report on Global Neurovascular Devices Market Research Report.
Problems related to the nervous system are serious. They cannot be seen easily, and their therapies usually lie in surgeries where patients and doctors need to decide which surgeries are more invasive and which are less invasive. Neurovascular devices are necessary for treating neurovascular diseases. These devices have been developed due to demand for minimally invasive procedures. There has never been a dearth of neurovascular patients. Therefore, the global neurovascular devices market has huge scope for growth. Factors contributing to the growth of this market include favorable reimbursement policies, and ongoing product development & commercialization.
Market Research Future (MRFR) has published a research report about the global neurovascular devices market that predicts the growth of this market between 2017 and 2023, with 8.8% CAGR. This report talks about the market scenario and future prospects regarding growth. In this report, the global neurovascular devices market has been segmented on the basis of end-user, product, therapeutic application, and lastly region.
On the basis of the end-users, this market has been segmented into ambulatory surgical units and hospitals & clinics. Ambulatory surgical units work for ambulatory surgery centers (ASC) that are also known as outpatient surgery centers, same-day surgery centers, or surgicenters. Ambulatory surgical units perform surgical procedures not requiring an overnight hospital stay. Such surgery is commonly less complicated than those required hospitalization.
The product based segmentation segments the market into aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, neuro thrombectomy devices, and a support device. The aneurysm coiling & embolization devices segment has been sub-segmented into embolic coils, flow diversion devices, and liquid embolic. Embolic coils block blood flow into an aneurysm (weak area of an artery). The embolic protection systems have been segmented into balloon occlusion devices and distal filter devices. Cerebral angioplasty is a procedure useful for opening the partially blocked carotid and vertebral arteries in the neck. They can also do the same for blood vessels within the brain. It has been segmented into is sub-segmented into carotid artery stents and embolic protection systems. Stenting system indicates an improvement of coronary luminal diameter in patients with symptomatic ischemic heart disease. Neurothrombectomy devices are used for treating acute ischemic strokes. They have been sub-segmented into aspiration devices, retrieval systems, and suction devices. Based on therapeutic application, the market has been segmented into the hemorrhagic stroke and ischemic strokes. A hemorrhagic stroke can be defined as either a brain aneurysm burst or a weakened blood vessel leak. The different types of ischemic strokes occur when the body is deprived of oxygen or any other important nutrients.
The regional segmentation of the global neurovascular devices market comprises of The Americas (North America & South America), Europe, Asia Pacific, and Middle East & Africa (MEA) region. The Americas dominate the global neurovascular devices market due to a large number of patients suffering from neurovascular diseases like arteriovenous malformations (AVMs) and brain aneurysm. Due to technological advancement, high disposable income, and the availability of better medical facilities, North America is the bigger market than South America. Moreover, increasing healthcare expenditure, government aid to researches in the field of medical sciences and the presence of the key players in North America boosts the growth of the market in North America. Majority key players in this region are based in the United States of America (USA).
Europe holds the second largest share in global neurovascular devices market. Increasing prevalence of the neurovascular diseases and the presence of a well-developed healthcare sector are the major factors that drive the market growth in this region. Due to reasons same as The Americas, Western Europe market is bigger than Eastern Europe. In Europe, most of the key players in this market are based in France and the United Kingdom (UK).
The Asia Pacific region is the fastest growing market for the market due to continuously developing economies like China and India, increasing demands for minimally invasive surgeries by the growing geriatric population, and the presence of a huge patient population. Asia Pacific region is yet to achieve the infrastructure development and technological advancement as par the level of North America and Europe, and there are few countries in this region that are technologically advanced. In the Asia Pacific region, the biggest markets are Australia, China, India, Japan, and South Korea, followed by the rest of Asia Pacific. MEA region is a small market due to political instability in most countries due to movements like Arab Spring. Lack of technology and less investment in healthcare due to healthcare not being considered a priority by governments in this region are the reasons for a small market. The biggest markets in this region are Kuwait, Oman, Saudi Arabia, Qatar, and United Arab Emirates (UAE), followed by rest of MEA region.
Key Players
The key players in the global neurovascular devices market include Abbott Laboratories (USA), Blockade Medical LLC. (France),  Delaware Corporation (USA), Evasc (Canada), Gynesonics (USA), Johnson & Johnson Services, Inc. (the USA), Medikit Co., Ltd. (Japan), Medtronic (USA), Merit Medical Systems Inc. (USA), MicroPort Scientific Corporation (China), Neuravi (Israel), OxfordEndovascular (UK), Penumbra, Inc. (USA), Rapid Medical (Israel), Sensome (France), Secant Group LLC (USA), Stryker (USA), Terumo Corporation (Japan), and W. L. Gore & Associates, Inc. (USA).
Latest Industry News
  • Israel based neurovascular device maker Rapid Medical has won Conformité Européene (CE) Mark approval in the European Union for its Tigertriever 13 stent retriever. This device is used for treating ischemic stroke. 31 JUL 2018
  • Israel-based medical device company Perflow Medical has announced the first clinical cases of the Cascade dynamic nonocclusive remodeling net, which is commercially available in Europe. 23 JUL 2018.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Recombinant DNA Technology Market - Size, Trends, Demand and Growth

Market Scenario
The recombinant DNA technology is a process that manipulates and alters the DNA sequences, resulting in a genetically modified organism and product. These genetically modified products or organisms have superior or specific ability such as resistance to certain chemicals, high productivity, and survival abilities in harsh conditions (GM crops).

Regional Analysis
The global recombinant DNA technology market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas region holds the largest market share of the global recombinant DNA technology market due to the presence of effective regulations pertaining to the approval of recombinant therapeutics and other Genetically Modified (GM) products. F. Hoffmann-La Roche Ltd, Amgen Inc., Novartis AG, Monsanto Company, Eli Lilly and Company, and Biogen Inc. are some of the major companies operating in this space that are responsible for the growth of the Americas recombinant DNA technology market.
Furthermore, there is an increasing need to improve the recombinant proteins production capacity by several folds in Europe. The increase in demand for effective therapeutics for the treatment of diseases and technological advancements in this sector are anticipated to drive the growth of the European recombinant DNA technology market.
Asia Pacific is expected to emerge as the fastest growing regional market for the global recombinant DNA technology market. The increasing awareness about the growing genetic diseases and disorders, developing healthcare infrastructure, increasing spending on healthcare, increasing government initiatives to improve public health, and advances in medical fields are driving the market growth.
The Middle East and Africa is expected to experience a limited growth due to less demand for genetic testing. The Middle East is growing significantly as compared to the African recombinant DNA technology market owing to the increase in aging population, innovations in genetic testing, and increase in the number of chronic disease cases. 


Segmentation
The global recombinant DNA technology market is segmented on the basis of product, component, application, and end-user.
On the basis of product, the global recombinant DNA technology market is segmented into medical, non-medical, and others. The medical segment is divided into therapeutic agent, human protein, and vaccines. The non-medical segment is divided into biotech crops, specialty chemicals, and others.
On the basis of component, the global recombinant DNA technology market is segmented into expression system, cloning vector, and others. The expression system segment is divided into mammalian, bacteria, yeast, baculovirus/insect, and others. The cloning vector segment is divided into plasmid, phage, cosmid, Bacterial Artificial Chromosome (BAC), Yeast Artificial Chromosome (YAC), and Human Artificial Chromosome (HAC).
On the basis of application, the global recombinant DNA technology market is segmented into food and agriculture, health and disease, environment, and others.
On the basis of end-user, the global recombinant DNA technology market is segmented into biotechnology companies, academic and government research institutes, pharmaceuticals, and others.
Key Players
Some of the key players in the global recombinant DNA technology market are F. Hoffmann-La Roche Ltd (Switzerland), Profacgen (U.S.), Amgen Inc. (U.S.), Novartis AG (Switzerland), Genscript Biotech (U.S.), Pfizer Inc. (U.S.), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Sanofi S.A. (France), Merck & Co., Inc. (U.S.), Biogen Inc. (U.S.), Biocon Limited (India), GlaxoSmithKline plc (UK), New England Biolabs (U.S.), Cibus (U.S.), Monsanto Company (U.S.), Horizon Discovery Group PLC (U.S.), Boehringer Ingelheim (Germany), and others.

Trending Report 



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Big Data Pharmaceutical Advertising Market Analysis Report 2020- Global Industry Trends by Forecast to 2023

Market Insights:
Market Research Report (MRFR)’s report has revealed that the global big data pharmaceutical advertising market is set to witness exponential growth and reach a valuation of USD 4477.3 Mn by the end of the forecast period. The growth is attributable to the strong value maintained by the pharmaceutical industry.
The intensified competitive landscape and the adoption of big data in the pharmaceutical industry for gaining an edge over competitors have accelerated revenue creation for the big data pharmaceutical advertising market players. The growing budgets for investments in advertising by the pharmaceutical companies are set to have a positive influence on the market proliferation. Furthermore, the increasing trend of digitalization has opened growth avenues for the market players.
Big data enhance the pathway to reach the targeted customers and optimizes costs associated with advertising. This has catalyzed its adoption in the pharmaceutical industry and is likely to augur well for the big data pharmaceutical advertising market expansion over the projection period. The market for big data pharmaceutical advertising resonates strong growth opportunities presently and is estimated to exhibit a steep rise in the market proliferation across the review period.

Market Segmentation:
By channel, the global big data pharmaceutical advertising market has been segmented into product website & e-commerce, social media, search engine, and mobile ads.
By application, the big data pharmaceutical advertising market is segmented into product & service targeting, customer targeting, and branding.


Regional Analysis:
By region, the global big data pharmaceutical advertising market has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America held the largest share of the market in 2015 which accounted for 42.3% share. It is likely to retain its prominence over the next couple of years and is estimated to reach a valuation of USD 1833.5 Mn by 2023. The growth is attributable to the developed healthcare sector, the presence of key players, intensified competition in the market, etc.
Europe is the second largest market for big data pharmaceutical advertising market currently. It is estimated to show positive growth throughout the forecast period. Meanwhile, Asia Pacific is projected to register a CAGR of 13% during the assessment period 2017 to 2023. The consolidation of fast-developing economies such as China and India are expected to boost the adoption of big data advertising in the pharmaceutical industry. However, the Middle East & Africa Big Data Pharmaceutical Advertising market is growing is expected to exhibit sluggish growth due to poor socio-economic conditions in the African countries.
Competitive Dashboard:
Some of the key players profiled in the report are International Business Machines Corporation (U.S.), Oracle (U.S.), Statistical Analysis System (U.S.), Tata Consultancy Services Limited (India), and TAKE Solutions Ltd (U.S.) among others.
Industry Developments:
In April 2018, Precisioneffect, the healthcare advertising agency has acquired Big Pink a leading European multichannel healthcare marketing agency.
In July 2018, Huntsworth Plc., the parent company of the Evoke Group of health and wellness marketing companies, acquired Giant Creative Strategy, focused on health care multi-channel marketing, backed by robust data and analytics offering.

Latest Trending Reports




About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

Medical Oxygen Concentrators Market in-depth approaches behind the Success Of Top Players like- Philips Healthcare, Invacare Corporation, AirSep Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed

Medical Oxygen Concentrators Market Highlights
The Global Medical Oxygen Concentrators Market held a market value of USD 1,755.8 Million in 2018 and is Projected to Grow at a CAGR of 7.8% Over the Forecast Period. Oxygen concentrator, also called as oxygen generator is a medical device used to deliver oxygen to the patient. This device concentrates the oxygen from a gas supply by removing nitrogen to supply an oxygen-enriched product gas stream. Stationary oxygen concentrators are used as stationary sources to provide long-term oxygen therapy (LTOT) to patients at home.
Oxygen concentrators provide supplementary oxygen for patients suffering from a chronic obstructive pulmonary disease (COPD) and in higher concentrations for pulmonary edema and severe chronic hypoxemia. In addition, this device is also used as an adjunct treatment for severe sleep apnea. Factors driving the market growth are worldwide increasing the number of patients requiring long-term oxygen therapy, rising prevalence of the chronic obstructive pulmonary disease, sleep apnea, and asthma, growth in healthcare spending, growing demand for portable oxygen concentrators, and the presence of favorable government initiatives. For instance, according to the data published by World Bank, in 2010, world’s current healthcare expenditure (% of gross domestic product — GDP) was 9.57% that was soared to 10.02% in 2016. In contrast, the high cost of oxygen concentrators and huge loss of oxygen and energy when continuous flow technology is used are anticipated to impede the market growth over the forecast period. Price range varies from USD 1,100 to 4,000 (2,300 typical) for stationary units and 3,995 to 5,700 (5,000 typical) for portable units.
Portable oxygen concentrators are oxygen machines that draw in oxygen with the use of a battery, electricity or DC power. These oxygen concentrators offer advantages such as compact in size, lightweight, improved efficiency, cost economic price, and mobility that enables patients to travel hassle-free. Technological advancements in the portable oxygen concentrators include pressure swing adsorption (PSA), and membrane technology is helping in the swift adoption of portable medical oxygen concentrators.
Medical Oxygen Concentrators Market Segmentation
The global medical oxygen concentrators market has been segmented into product, technology, indication, end user, and region.
By product, the market has been segmented into portable oxygen concentrators and stationary oxygen concentrators.
On the basis of technology, the market has been divided into the continuous flow and pulse dose.
Based on indication, the market has been categorized into chronic obstructive pulmonary disease, asthma, sleep apnea, and others.
By end user, the market has been classified into homecare, travel, hospitals and clinics, and others. Home oxygen concentrators facilitate convenience and make it easier and safer for the patient to complete their day-to-day activities, which is supporting the dominance of the homecare segment during the next six years.
Medical Oxygen Concentrators Market Key Players
Few of the prominent players in the global medical oxygen concentrators market are Philips Healthcare, AirSep Corporation, Invacare Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart Industries, Inc., Nidek Medical Products, Inc., Inogen, Precision Medical, Inc., GCE Group, Besco Medical Limited, O2 Concepts, LLC, Teijin Limited, and OSI - Oxygen Solutions Inc.
Regional Analysis
The global medical oxygen concentrators market has been categorized on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas is expected to dominate the market over the forecast period due to the presence of favorable government initiatives, reimbursement policies, and major market participants developed home healthcare care services and higher adoption of portable oxygen concentrators for homecare needs. Higher value contributors based in the US are Philips Healthcare, Invacare Corporation, AirSep Corporation, ResMed, and Precision Medical, Inc. In addition, government initiatives including the presence of the Federal Aviation Administration (FAA), which authorize the use of portable concentrators during air travel are promoting the dominance of the Americas.
Europe would follow the Americas in terms of revenue over the forecast period as the German government has been undertaking several initiatives to reduce pollution levels in the country and promote public health. In November 2018, the German government unveiled a 5-point plan to reduce plastic waste.
The market in Asia-Pacific would showcase comparatively higher CAGR during the forecast period. This is owing to rising prevalence of COPD and asthma, increasing spending on healthcare, growing awareness about state-of-the-art technologies in an oxygen concentrator, rising adoption of portable units, growth in disposable income, and changing diet pattern and lifestyle resulting in the development of diseases. As per data published in The Lancet journal, in 2016, the prevalence of COPD in India was 4·2% and the prevalence of asthma 2·9%. India has a higher prevalence of COPD than the global average, as well as more disability-adjusted life-years (DALYs) per person with COPD or asthma than the global average.
The Middle East & Africa has the least share of the global medical oxygen concentrators market. In addition, the major market share of the region would be held by the Middle Eastern region due to developing healthcare system and medical infrastructure in the Arab countries.

Trending Reports


About Market Research Future: 
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels: , , ,

What’s Driving the Patient Registry Software Market | Top Players in the Current Competition are: ArborMetrix, Dacima Software Inc, Evado Pty. Ltd, IFA SYSTEMS, Open Text Corporation, LUMEDX, McKesson Corporation, Optum, Inc.

The Global Patient Registry Software Market is expected to register a CAGR of 11.08% during the forecast period with a market value of USD 1,998.83 Million till 2025.
Patient registry software is an organized system that utilizes observational study methods for collecting clinical as well as non-clinical patient data for evaluation of specified outcomes for a population that is defined by a particular disease, condition, or exposure, and that serves a predetermined clinical, scientific, or policy purposes.
The high adoption rate of electronic health records and increasing use of patient registry data for post-marketing surveillance is anticipated to drive the market growth of the global patient registry software market. However, privacy and data security-related concerns are expected to restrict the market growth.
Global Patient Registry Software Market: Segmental Analysis
The global patient registry software market has been segmented on the basis of deployment model, software, type of registry, and end user.
By mode of software, the global patient registry software market has been segmented into standalone and integrated. Among these, the integrated software is estimated to project the largest market share.
By mode of deployment model, the global patient registry software market has been segmented into on-premise model and cloud-based model. Among these, the cloud-based model is expected to occupy the largest market share owing to its increased adoption throughout the assessment period.
By mode of type, the global patient registry software market has been segmented into disease registries and product registries.
By mode of end-users, the global patient registry software market has been segmented into hospitals & medical centers, pharmaceutical & medical device companies, government & non-government agencies, and others. Among these, the pharmaceutical & medical device companies’ segment is estimated to occupy the largest share in the market.
Regional Insights
Geographically, the patient registry software market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.
Considering the global scenario, the American region is considered to dominate the global patient registry software market. The growth is credited to the increased use of patient registry data for post-marketing surveillance, the presence of well-established players, and surging adoption EHRs in this region. Moreover, the increased number of registered hospitals coupled with the growing number of patient visits for physical checkups are some of the major factors likely to drive the market in this region.
The Asia Pacific region is predicted to create new opportunities for the market. Several initiatives undertaken by the government in order to enhance population health management is driving the market growth in this region. Moreover, the rising pressure of the government on the healthcare organizations in order to minimize the cost of healthcare and improve the quality of care is estimated to foster the market growth in this region.
Industry Updates
On January 2018, a leading innovator in EDC technology named Dacima Software, Inc. announced that they have signed a contract with the Derby Teaching Hospital and have been awarded an RFP in the U.K. for the use of Dacima’s Electronic Data Capture software.
Competitive Dashboard
The prominent players operating in the patient registry software market are Liaison Technologies. (US), Phytel Inc. (US), IFA systems AG (Germany), QUINTILES IMS HOLDINGS INC. (US), FIGmd Inc. (US), McKesson Corporation (US), ImageTrend Inc. (US), Dacima Software Inc. (US), CECity.com Inc. (US), and Global Vision Technologies Inc. (US).
Most Trending Reports
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)